Why Did Biodexa Pharmaceuticals' Stock Drop After-Hours Despite Big Gain During Regular Trading?

Benzinga_recent_news10-10

Biodexa Pharmaceuticals PLC-ADR (NASDAQ:BDRX) saw its stock fall 3.67% to $10.50 during after-hours trading on Thursday. Check out the current price of BDRX stock here. According to Benzinga Pro data,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2574914616?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/10/10/Stockmarket-Online-Trading-Chart-Candles.jpeg?optimize=medium&dpr=2&auto=webp&width=240","is_english":true,"pubTime":"2025-10-10 12:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2574914616","market":"us","top_or_hot":-1,"title":"Why Did Biodexa Pharmaceuticals' Stock Drop After-Hours Despite Big Gain During Regular Trading?","media":"Benzinga_recent_news","content":"<div>\n<p>Biodexa Pharmaceuticals PLC-ADR (NASDAQ:BDRX) saw its stock fall 3.67% to $10.50 during after-hours trading on Thursday.\nCheck out the current price of BDRX stock here.\nAccording to Benzinga Pro data,...</p>\n\n<a href=\"https://www.benzinga.com/markets/equities/25/10/48141247/why-did-biodexa-pharmaceuticals-stock-drop-after-hours-despite-big-gain-during-regular-trading\">Source Link</a>\n\n</div>\n","source":"benzinga_recent_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Did Biodexa Pharmaceuticals' Stock Drop After-Hours Despite Big Gain During Regular Trading?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Did Biodexa Pharmaceuticals' Stock Drop After-Hours Despite Big Gain During Regular Trading?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-10-10 12:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/markets/equities/25/10/48141247/why-did-biodexa-pharmaceuticals-stock-drop-after-hours-despite-big-gain-during-regular-trading><strong>Benzinga_recent_news</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Biodexa Pharmaceuticals PLC-ADR (NASDAQ:BDRX) saw its stock fall 3.67% to $10.50 during after-hours trading on Thursday.\nCheck out the current price of BDRX stock here.\nAccording to Benzinga Pro data,...</p>\n\n<a href=\"https://www.benzinga.com/markets/equities/25/10/48141247/why-did-biodexa-pharmaceuticals-stock-drop-after-hours-despite-big-gain-during-regular-trading\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://www.benzinga.com/markets/equities/25/10/48141247/why-did-biodexa-pharmaceuticals-stock-drop-after-hours-despite-big-gain-during-regular-trading","article_id":"2574914616","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/10/10/Stockmarket-Online-Trading-Chart-Candles.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/25/10/48141247/why-did-biodexa-pharmaceuticals-stock-drop-after-hours-despite-big-gain-during-regular-trading","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2574914616","pubTimestamp":1760071740,"columns":[],"sourceInfo":{"source_id":"benzinga_recent_news","name":"Benzinga"},"weMediaInfo":null,"summary":"Biodexa's stock dipped 3.67% to $10.50 in after-hours trading following a strong gain during the regular session.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","BDRX":"BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD"},"translate_title":"为什么Biodexa Pharmaceuticals的股价在常规交易中大幅上涨，但盘后仍下跌？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BDRX":1},"content_text":"Biodexa Pharmaceuticals PLC-ADR (NASDAQ:BDRX) saw its stock fall 3.67% to $10.50 during after-hours trading on Thursday.\nCheck out the current price of BDRX stock here.\nAccording to Benzinga Pro data, after closing the regular session at $10.90, up $3.19 or 41.37%, the stock of the biotech then dropped to $10.50 in after-hours trading.\nOn Monday, Biodexa announced it will host a breakfast symposium at the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer annual meeting, taking place in St. Louis from October 9-11. \nThe company shared a post about the event on their social media on Tuesday.\nAccording to a company press release, Dr. Patrick Lynch, retired Professor of Medicine from the University of Texas MD Anderson Cancer Center, will speak on “FAP mechanisms and Chemoprevention Trial Issues.”\nSee Also: Levi Strauss Stock Slips Despite Q3 Earnings Beat\nAn interactive panel discussion will follow, featuring Dr. Sonia S. Kupfer, Professor of Medicine at the University of Chicago, and Dr. Paul E. Wise, Professor of Surgery at Washington University.\nDr. Gary Shangold, Chief Medical Officer of Biodexa, stated, “We are honored to convene this distinguished panel at such a prestigious scientific forum.” The company is moving forward with its Phase 3 Serenta trial of eRapa, a proprietary oral rapamycin formulation aimed at treating familial adenomatous polyposis.\nOver the past year, the Biodexa Pharmaceuticals experienced a decline of 77.24%, followed by a 30.57% drop over the last six months. However, in a remarkable turnaround, it has surged 89.90% in the past month, showing signs of strong recovery and renewed investor interest.\nShares of the UK-based clinical-stage company has fluctuated widely this year, ranging from a low of $5.00 to a high of $108.90. It has a market capitalization of $6.75 million and an average daily trading volume of around 44,840 shares.\nBenzinga’s Edge Stock Rankings indicate that BDRX is experiencing short-term upward movement along with medium and long-term consolidation. Here is how the stock fares on other parameters.\nRead Next:\nPhoto courtesy: Korot Yurii on Shutterstock.com\nDisclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2574914616","isCrawlerRequest":true}